Current status of circulating protein biomarkers to aid the early detection of lung cancer
- PMID: 25052758
- DOI: 10.2217/fon.14.21
Current status of circulating protein biomarkers to aid the early detection of lung cancer
Abstract
Considerable efforts have been undertaken to produce an effective screening method to reduce lung cancer mortality. Imaging tools such as low-dose computed tomography has shown an increase in the detection of early disease and a reduction in the rate of death. This screening modality has, however, several limitations, such as overdiagnosis and a high rate of false positives. Therefore, new screening methods, such as the use of circulating protein biomarkers, have emerged as an option that could complement imaging studies. In this review, current imaging techniques applied to lung cancer screening protocols are presented, as well as up-to-date status of circulating protein biomarker panels that may improve lung cancer diagnosis. Additionally, diverse statistical and artificial intelligence tools applied to the design and optimization of these panels are discussed along with the presentation of two commercially available blood tests recently developed to help detect lung cancer early.
Keywords: blood test; data analysis methods; early detection; high-risk population; lung cancer; multiple biomarker panels; screening.
Similar articles
-
[Present Situation of Lung Cancer Screening Methods].Zhongguo Fei Ai Za Zhi. 2016 Oct 20;19(10):715-720. doi: 10.3779/j.issn.1009-3419.2016.10.14. Zhongguo Fei Ai Za Zhi. 2016. PMID: 27760605 Free PMC article. Review. Chinese.
-
Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging.Expert Rev Mol Diagn. 2015 Jun;15(6):801-13. doi: 10.1586/14737159.2015.1041377. Epub 2015 Apr 30. Expert Rev Mol Diagn. 2015. PMID: 25924864 Review.
-
Early detection of lung cancers - Comparison of computed tomography, cytology and fuzzy-based tumor markers panels.Cancer Biomark. 2010;6(3-4):149-62. doi: 10.3233/CBM-2009-0126. Cancer Biomark. 2010. PMID: 20660961 Review.
-
A review of novel biological tools used in screening for the early detection of lung cancer.Postgrad Med J. 2009 Jul;85(1005):358-63. doi: 10.1136/pgmj.2008.076307. Postgrad Med J. 2009. PMID: 19581246 Review.
-
Molecular diagnosis of lung cancer: an overview of recent developments.Acta Biomed. 2008;79 Suppl 1:11-23. Acta Biomed. 2008. PMID: 18924306 Review.
Cited by
-
Artificial Intelligence and Lung Cancer: Impact on Improving Patient Outcomes.Cancers (Basel). 2023 Oct 31;15(21):5236. doi: 10.3390/cancers15215236. Cancers (Basel). 2023. PMID: 37958411 Free PMC article. Review.
-
Circulating proteome for pulmonary nodule malignancy.J Natl Cancer Inst. 2023 Sep 7;115(9):1060-1070. doi: 10.1093/jnci/djad122. J Natl Cancer Inst. 2023. PMID: 37369027 Free PMC article.
-
Diagnostic and prognostic value of serum miR-145 and vascular endothelial growth factor in non-small cell lung cancer.Oncol Lett. 2022 Jan;23(1):12. doi: 10.3892/ol.2021.13130. Epub 2021 Nov 11. Oncol Lett. 2022. PMID: 34820011 Free PMC article.
-
Green Metallic Nanoparticles for Cancer Therapy: Evaluation Models and Cancer Applications.Pharmaceutics. 2021 Oct 18;13(10):1719. doi: 10.3390/pharmaceutics13101719. Pharmaceutics. 2021. PMID: 34684012 Free PMC article. Review.
-
High-throughput assessment of the antibody profile in ovarian cancer ascitic fluids.Oncoimmunology. 2019 Jun 4;8(9):e1614856. doi: 10.1080/2162402X.2019.1614856. eCollection 2019. Oncoimmunology. 2019. PMID: 31428516 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical